Literature DB >> 24368725

The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention.

Deng Ke-Wu1, Shi Xu-Bo2, Zhao Ying-Xin3, Yang Shi-Wei3, Zhou Yu-Jie4, Shi Dong-Mei3, Liu Yu-Yang3, Jia De-An3, Fang Zhe3, Zhou Zhi-Ming3, Ge Hai-Long3, Yan Zhen-Xian3, Ma Chang-Sheng1.   

Abstract

OBJECTIVE: To evaluate the effect of exogenous creatine phosphate (CP) on myocardial injury after percutaneous coronary intervention (PCI).
METHOD: Four hundred patients were divided to receive conventional therapy (control group) or 3-day intravenous infusion of CP after PCI (CP group). Levels of creatine kinase MB (CK-MB) and troponin I (TnI) were measured before and on postprocedural day 3.
RESULTS: Postprocedural CK-MB and TnI in the CP group were significantly increased compared to the control group. In the CP group, 8.0% and 5.0% of patients had an increase in CK-MB 1 to 3 times and >3 times, respectively, which were significantly lower than that of the control group (19.0% and 9.0%, respectively); 12.0% and 10.0% of patients had an increase in TnI 1 to 3 times and >3 times, respectively, which were significantly lower than that of the control group (21.0% and 18.0%, respectively).
CONCLUSION: Exogenous CP was helpful to reduce myocardial injury after PCI.
© The Author(s) 2013.

Entities:  

Keywords:  creatine phosphate; myocardial injury; percutaneous coronary intervention

Mesh:

Substances:

Year:  2013        PMID: 24368725     DOI: 10.1177/0003319713515996

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  Effects and mechanisms of glucose-insulin-potassium on post-procedural myocardial injury after percutaneous coronary intervention.

Authors:  Yi-Dan Hao; Peng Hao; Zheng Wang; Ying-Xin Zhao; Zhi-Ming Zhou; Yu-Yang Liu; De-An Jia; Hong-Ya Han; Bin Hu; Hua Shen; Fei Gao; Guo-Zhong Pan; Zhen-Feng Guo; Shi-Wei Yang; Yu-Jie Zhou
Journal:  J Geriatr Cardiol       Date:  2020-09-28       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.